Surfactant-free poly(lactide-co-glycolide) nanoparticles for improving in vitro anticancer efficacy of tetrandrine

References

• Bilati U, All Mann E, Doelker E. Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. Eur J Pharm Sci, 2005;24:67–75.
   PubMed Web of Science ®Google Scholar
• Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev, 2004;56:1649–59.
   PubMed Web of Science ®Google Scholar
• Budhian A, Siegel SJ, Winey KI. Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles. Int J Pharm, 2008;346:151–9.
   PubMed Web of Science ®Google Scholar
• Butler MS. The role of natural product chemistry in drug discovery. J Nat Prod, 2004;67:2141–53.
   PubMed Web of Science ®Google Scholar
• Cheng FY, Wang SPH, Su CH, Tsai TL, Wu PC, Shieh DB, Chen JH, Hsieh PCH, Yeh CS. Stabilizer-free poly(lactide-co-glycolide) nanoparticles for multimodal biomedical probes. Biomaterials, 2008;29:2104–12.
   PubMed Web of Science ®Google Scholar
• Cho HS, Chang SH, Chung YS, Shin JY, Park SJ, Lee ES, Hwang SK, Kwon JT, Tehrani AM, Woo M, et al. Synergistic effect of ERK inhibition on tetrandrine-induced apoptosis in A549 human lung carcinoma cells. J Vet Sci, 2009;10:23–8.
   PubMed Web of Science ®Google Scholar
• Corrigan OI, Li X. Quantifying drug release from PLGA nanoparticulates. Eur J Pharm Sci, 2009;37:477–85.
   PubMed Web of Science ®Google Scholar
• Cragg GM, Newman DJ. Natural products: A continuing source of novel drug leads. Biochim Biophys Acta, 2013;1830:3670–95.
   PubMed Web of Science ®Google Scholar
• Demerlis CC, Schoneker DR. Review of the oral toxicity of polyvinyl alcohol (PVA). Food Chem Toxicol, 2003;41:319–26.
   PubMed Web of Science ®Google Scholar
• Dinarvand R, Sepehri N, Manoochehri S, Rouhani H, Atyabi F. Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. Int J Nanomedicine, 2011;6:877–95.
   PubMed Web of Science ®Google Scholar
• Esmaeili F, Ghahremani MH, Esmaeili B, Khoshayand MR, Atyabi F, Dinarvand R. PLGA nanoparticles of different surface properties: Preparation and evaluation of their body distribution. Int J Pharm, 2008;349:249–55.
   PubMed Web of Science ®Google Scholar
• Govender T, Stolnik S, Garnett MC, Illum L, Davis SS. PLGA nanoparticles prepared by nanoprecipitation: Drug loading and release studies of a water soluble drug. J Control Release, 1999;57:171–85.
   PubMed Web of Science ®Google Scholar
• Grabowski N, Hillaireau H, Vergnaud J, Tsapis N, Pallardy M, Kerdine-R Mer S, Fattal E. Surface coating mediates the toxicity of polymeric nanoparticles towards human-like macrophages. Int J Pharm, 2015;482:75–83.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell, 2011;144:646–74.
   PubMed Web of Science ®Google Scholar
• Hariharan S, Bhardwaj V, Bala I, Sitterberg J, Bakowsky U, Ravi KMN. Design of estradiol loaded PLGA nanoparticulate formulations: A potential oral delivery system for hormone therapy. Pharm Res, 2006;23:184–95.
   PubMed Web of Science ®Google Scholar
• Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials, 2000;21:2475–90.
   PubMed Web of Science ®Google Scholar
• Jose JPM, Venkadesh B, Hussain R, Rajendra PN, Shibli SMA, Raj AV, Rajan SS. Paclitaxel loaded poly-d, l-lactide-co-glycolide nanoparticles: Enhanced anticancer effect in non-small cell lung carcinoma cell line. Biomed Prev Nutr, 2013;3:1–9.
   Google Scholar
• Kerr JF, Winterford CM, Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer, 1994;73:2013–26.
   PubMed Web of Science ®Google Scholar
• Kingsley JD, Dou H, Morehead J, Rabinow B, Gendelman HE, Destache CJ. Nanotechnology: a focus on nanoparticles as a drug delivery system. J Neuroimmune Pharmacol, 2006;1:340–50.
   PubMed Web of Science ®Google Scholar
• Kwon HY, Lee JY, Choi SW, Jang Y, Kim JH. Preparation of PLGA nanoparticles containing estrogen by emulsification–diffusion method. Colloids Surf A Physicochem Eng Asp, 2001;182:123–30.
   Web of Science ®Google Scholar
• Lai JH. Immunomodulatory effects and mechanisms of plant alkaloid tetrandrine in autoimmune diseases. Acta Pharmacol Sin, 2002;23:1093–101.
   PubMed Web of Science ®Google Scholar
• Li R, Li X, Xie L, Ding D, Hu Y, Qian X, Yu L, Ding Y, Jiang X, Liu B. Preparation and evaluation of PEG-PCL nanoparticles for local tetradrine delivery. Int J Pharm, 2009;379:158–66.
   PubMed Web of Science ®Google Scholar
• Li X, Li R, Qian X, Ding Y, Tu Y, Guo R, Hu Y, Jiang X, Guo W, Liu B. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate. Eur J Pharm Biopharm, 2008;70:726–34.
   PubMed Web of Science ®Google Scholar
• Liou JT, Chen ZY, Ho LJ, Yang SP, Chang DM, Liang CC, Lai JH. Differential effects of triptolide and tetrandrine on activation of COX-2, NF-kappaB, and AP-1 and virus production in dengue virus-infected human lung cells. Eur J Pharmacol, 2008;589:288–98.
   PubMed Web of Science ®Google Scholar
• Menon JU, Kona S, Wadajkar AS, Desai F, Vadla A, Nguyen KT. Effects of surfactants on the properties of PLGA nanoparticles. J Biomed Mater Res, 2012;100:1998–2005.
   Web of Science ®Google Scholar
• Murakami H, Kobayashi M, Takeuchi H, Kawashima Y. Preparation of poly(dl-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. Int J Pharm, 1999;187:143–52.
   PubMed Web of Science ®Google Scholar
• Murakami H, Kobayashi M, Takeuchi H, Kawashima Y. Further application of a modified spontaneous emulsification solvent diffusion method to various types of PLGA and PLA polymers for preparation of nanoparticles. Powder Technol, 2000;107:137–43.
   Web of Science ®Google Scholar
• Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod, 2012;75:311–35.
   PubMed Web of Science ®Google Scholar
• Panyam J, Sahoo SK, Prabha S, Bargar T, Labhasetwar V. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(d, l-lactide-co-glycolide) nanoparticles. Int J Pharm, 2003;262:1–11.
   PubMed Web of Science ®Google Scholar
• Roberts AD, Zhang H. Poorly water-soluble drug nanoparticles via solvent evaporation in water-soluble porous polymers. Int J Pharm, 2013;447:241–50.
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (d, l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release, 2002;82:105–14.
   PubMed Web of Science ®Google Scholar
• Sakuma S, Hayashi M, Akashi M. Design of nanoparticles composed of graft copolymers for oral peptide delivery. Adv Drug Deliv Rev, 2001;47:21–37.
   PubMed Web of Science ®Google Scholar
• Santander-Ortega MJ, Dar-Reyes J, Csaba AB, Bastos-Gonz Lez N, Ortega-Vinuesa D. JL, Colloidal stability of Pluronic F68-coated PLGA nanoparticles: A variety of stabilisation mechanisms. J Colloid Interface Sci, 2006;302:522–9.
   PubMed Web of Science ®Google Scholar
• Sasnauskiene A, Kadziauskas J, Vezelyte N, Jonusiene V, Kirveliene V. Apoptosis, autophagy and cell cycle arrest following photodamage to mitochondrial interior. Apoptosis, 2009;14:276–86.
   PubMed Web of Science ®Google Scholar
• Shah U, Shah R, Acharya S, Acharya N. Novel anticancer agents from plant sources. Chin J Nat Med, 2013;11:16–23.
   Web of Science ®Google Scholar
• Shakweh M, Besnard M, Nicolas V, Fattal E. Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by Peyer's patches in mice. Eur J Pharm Biopharm, 2005;61:1–13.
   PubMed Web of Science ®Google Scholar
• Tahara K, Furukawa S, Yamamoto H, Kawashima Y. Hybrid-modified poly(D, L-lactide-co-glycolide) nanospheres for a novel cellular drug delivery system. Int J Pharm, 2010;392:311–13.
   PubMed Web of Science ®Google Scholar
• Vandervoort J, Ludwig A. Biocompatible stabilizers in the preparation of PLGA nanoparticles: A factorial design study. Int J Pharm, 2002;238:77–92.
   PubMed Web of Science ®Google Scholar
• Xu Q, Chin SE, Wang CH, Pack DW. Mechanism of drug release from double-walled PDLLA(PLGA) microspheres. Biomaterials, 2013;34:3902–11.
   PubMed Web of Science ®Google Scholar
• Xu W, Debeb BG, Lacerda L, Li J, Woodward WA. Tetrandrine, a compound common in chinese traditional medicine, preferentially kills breast cancer Tumor Initiating Cells (TICs) in vitro. Cancers (Basel), 2011;3:2274–85.
   PubMedGoogle Scholar
• Yan F, Zhang C, Zheng Y, Mei L, Tang L, Song C, Sun H, Huang L. The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity. Nanomedicine, 2010;6:170–8.
   PubMed Web of Science ®Google Scholar